Revised SPC: Asacol (mesalazine) preparations

Drug reaction with eosinophilia and systemic symptoms (DRESS) has been added as a potential adverse effect (frequency unknown). It should be discontinued at first appearance of signs/symptoms of severe skin reactions, eg. rash, mucosal lesions, or other signs of hypersensitivity.

Source:

electronic Medicines compendium